Loading company…
PhoenixBio Co., Ltd. develops life science products, including PXB mice with human liver cells and cryopreserved human liver cells.
PXB mice have over 70% of their liver replaced with human hepatocytes and are used in pharmaceutical research and toxicology studies. Customers include pharmaceutical companies, academic institutions, and research organizations in North America, Europe, and Asia. Founded in 2002 and based in Higashihiroshima, Japan, the company is at the Series A stage and raised JPY 1.5 billion in a PIPE round completed in March 2020, with investments from Sanwa Starch Co., Ltd. and Whiz Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in